Skip to main content
PMC home page
Gut logoLink to Gut
. 1993 Apr;34(4):461–465. doi: 10.1136/gut.34.4.461

Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs.

A S Taha 1, J Reid 1, P Boothmann 1, C G Gemmell 1, F D Lee 1, R D Sturrock 1, R I Russell 1
PMCID: PMC1374303  PMID: 8491390

Abstract

The host's humoral immune response to Helicobacter pylori has been used in the diagnosis of active infection with these organisms. Several commercial tests are available but there are few and unconfirmed reports of their efficacy. This study aimed to assess and compare the efficacy of the following H pylori serological tests in patients treated or not treated with non-steroidal anti-inflammatory drugs (NSAID): Pyloriset Latex, Helico-G, Biolab Malakit, and Bio-Rad GAP Test IgG. Venous blood was tested at random in 124 patients, 64 of whom had received NSAID and 60 who had not. H pylori IgG antibodies were detected by latex agglutination (Pyloriset), or by ELISA (the remaining tests). Endoscopic gastric antral biopsy specimens were also obtained for urease activity, culture, and histology. Detection of H pylori by at least two of these was considered as a true positive, and its absence in all biopsy specimens as a true negative. The sensitivity values in the presence (or absence) of NSAID were: Pyloriset Latex, 59 (60)%; Helico-G, 79 (74)%; Biolab Malakit, 85 (81)%; and Bio-Rad GAP Test IgG, 100 (95)%. The respective specificity values were: 50 (71)%, 47 (59)%, 50 (65)%, and 30 (29)%. The Bio-Rad GAP Test IgG has the highest sensitivity and the lowest specificity values regardless of NSAID intake. The sensitivity of the other tests, however, is less than that of the standard biopsy related tests and their specificity is even lower in chronic NSAID users.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Caselli M., Pazzi P., LaCorte R., Aleotti A., Trevisani L., Stabellini G. Campylobacter-like organisms, nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis. Digestion. 1989;44(2):101–104. doi: 10.1159/000199898. [DOI] [PubMed] [Google Scholar]
  2. Crabtree J. E., Shallcross T. M., Heatley R. V., Wyatt J. I. Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. J Clin Pathol. 1991 Apr;44(4):326–328. doi: 10.1136/jcp.44.4.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Das S. S., Karim Q. N., Easmon C. S. Opsonophagocytosis of Campylobacter pylori. J Med Microbiol. 1988 Oct;27(2):125–130. doi: 10.1099/00222615-27-2-125. [DOI] [PubMed] [Google Scholar]
  4. Dixon M. F., O'Connor H. J., Axon A. T., King R. F., Johnston D. Reflux gastritis: distinct histopathological entity? J Clin Pathol. 1986 May;39(5):524–530. doi: 10.1136/jcp.39.5.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dixon M. F., Wyatt J. I., Burke D. A., Rathbone B. J. Lymphocytic gastritis--relationship to Campylobacter pylori infection. J Pathol. 1988 Feb;154(2):125–132. doi: 10.1002/path.1711540204. [DOI] [PubMed] [Google Scholar]
  6. Evans D. J., Jr, Evans D. G., Graham D. Y., Klein P. D. A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology. 1989 Apr;96(4):1004–1008. doi: 10.1016/0016-5085(89)91616-8. [DOI] [PubMed] [Google Scholar]
  7. Fox J. G., Correa P., Taylor N. S., Zavala D., Fontham E., Janney F., Rodriguez E., Hunter F., Diavolitsis S. Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol. 1989 Jul;84(7):775–781. [PubMed] [Google Scholar]
  8. Goodwin C. S., Blincow E., Peterson G., Sanderson C., Cheng W., Marshall B., Warren J. R., McCulloch R. Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa. J Infect Dis. 1987 Mar;155(3):488–494. doi: 10.1093/infdis/155.3.488. [DOI] [PubMed] [Google Scholar]
  9. Graham D. Y. Helicobacter pylori and the endoscopist: whether to diagnose. Gastrointest Endosc. 1991 Sep-Oct;37(5):577–579. doi: 10.1016/s0016-5107(91)70838-9. [DOI] [PubMed] [Google Scholar]
  10. Graham D. Y., Klein P. D., Opekun A. R., Boutton T. W. Effect of age on the frequency of active Campylobacter pylori infection diagnosed by the [13C]urea breath test in normal subjects and patients with peptic ulcer disease. J Infect Dis. 1988 Apr;157(4):777–780. doi: 10.1093/infdis/157.4.777. [DOI] [PubMed] [Google Scholar]
  11. Horan M. A., Fox R. A. Ageing and the immune response--a unifying hypothesis? Mech Ageing Dev. 1984 Aug;26(2-3):165–181. doi: 10.1016/0047-6374(84)90091-5. [DOI] [PubMed] [Google Scholar]
  12. Jones D. M., Eldridge J., Fox A. J., Sethi P., Whorwell P. J. Antibody to the gastric campylobacter-like organism ("Campylobacter pyloridis")--clinical correlations and distribution in the normal population. J Med Microbiol. 1986 Aug;22(1):57–62. doi: 10.1099/00222615-22-1-57. [DOI] [PubMed] [Google Scholar]
  13. Jones D. M., Lessells A. M., Eldridge J. Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies. J Clin Pathol. 1984 Sep;37(9):1002–1006. doi: 10.1136/jcp.37.9.1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jones S. T., Clague R. B., Eldridge J., Jones D. M. Serological evidence of infection with Helicobacter pylori may predict gastrointestinal intolerance to non-steroidal anti-inflammatory drug (NSAID) treatment in rheumatoid arthritis. Br J Rheumatol. 1991 Feb;30(1):16–20. doi: 10.1093/rheumatology/30.1.16. [DOI] [PubMed] [Google Scholar]
  15. Karnes W. E., Jr, Samloff I. M., Siurala M., Kekki M., Sipponen P., Kim S. W., Walsh J. H. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology. 1991 Jul;101(1):167–174. doi: 10.1016/0016-5085(91)90474-y. [DOI] [PubMed] [Google Scholar]
  16. Marshall B. J., McGechie D. B., Rogers P. A., Glancy R. J. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust. 1985 Apr 15;142(8):439–444. doi: 10.5694/j.1326-5377.1985.tb113444.x. [DOI] [PubMed] [Google Scholar]
  17. Martin D. F., Montgomery E., Dobek A. S., Patrissi G. A., Peura D. A. Campylobacter pylori, NSAIDS, and smoking: risk factors for peptic ulcer disease. Am J Gastroenterol. 1989 Oct;84(10):1268–1272. [PubMed] [Google Scholar]
  18. Meyer B., Werth B., Beglinger C., Dill S., Drewe J., Vischer W. A., Eggers R. H., Bauer F. E., Stalder G. A. Helicobacter pylori infection in healthy people: a dynamic process? Gut. 1991 Apr;32(4):347–350. doi: 10.1136/gut.32.4.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Newell D. G. Identification of the outer membrane proteins of Campylobacter pyloridis and antigenic cross-reactivity between C. pyloridis and C. jejuni. J Gen Microbiol. 1987 Jan;133(1):163–170. doi: 10.1099/00221287-133-1-163. [DOI] [PubMed] [Google Scholar]
  20. Perez-Perez G. I., Blaser M. J. Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun. 1987 May;55(5):1256–1263. doi: 10.1128/iai.55.5.1256-1263.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Perez-Perez G. I., Dworkin B. M., Chodos J. E., Blaser M. J. Campylobacter pylori antibodies in humans. Ann Intern Med. 1988 Jul 1;109(1):11–17. doi: 10.7326/0003-4819-109-1-11. [DOI] [PubMed] [Google Scholar]
  22. Rathbone B. J., Wyatt J. I., Worsley B. W., Shires S. E., Trejdosiewicz L. K., Heatley R. V., Losowsky M. S. Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut. 1986 Jun;27(6):642–647. doi: 10.1136/gut.27.6.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sobala G. M., Crabtree J. E., Pentith J. A., Rathbone B. J., Shallcross T. M., Wyatt J. I., Dixon M. F., Heatley R. V., Axon A. T. Screening dyspepsia by serology to Helicobacter pylori. Lancet. 1991 Jul 13;338(8759):94–96. doi: 10.1016/0140-6736(91)90085-4. [DOI] [PubMed] [Google Scholar]
  24. Sobala G. M., King R. F., Axon A. T., Dixon M. F. Reflux gastritis in the intact stomach. J Clin Pathol. 1990 Apr;43(4):303–306. doi: 10.1136/jcp.43.4.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sugiyama T., Imai K., Yoshida H., Takayama Y., Yabana T., Yokota K., Oguma K., Yachi A. A novel enzyme immunoassay for serodiagnosis of Helicobacter pylori infection. Gastroenterology. 1991 Jul;101(1):77–83. doi: 10.1016/0016-5085(91)90462-t. [DOI] [PubMed] [Google Scholar]
  26. Taha A. S., Boothman P., Holland P., McKinlay A., Upadhyay R., Kelly R. W., Lee F., Russell R. I. Gastric mucosal prostaglandin synthesis in the presence of Campylobacter pylori in patients with gastric ulcers and non-ulcer dyspepsia. Am J Gastroenterol. 1990 Jan;85(1):47–50. [PubMed] [Google Scholar]
  27. Taha A. S., Nakshabendi I., Lee F. D., Sturrock R. D., Russell R. I. Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration. J Clin Pathol. 1992 Feb;45(2):135–139. doi: 10.1136/jcp.45.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Veenendaal R. A., Peña A. S., Meijer J. L., Endtz H. P., van der Est M. M., van Duijn W., Eulderink F., Kreuning J., Lamers C. B. Long term serological surveillance after treatment of Helicobacter pylori infection. Gut. 1991 Nov;32(11):1291–1294. doi: 10.1136/gut.32.11.1291. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES